Central line-associated bloodstream infection (CLABSI) occurrence is arguably 100% preventable, yet central venous access device (CVAD) related infections have a 12-25% mortality rate in the ICU setting1. One to 2 of every 8 patients who develop CLABSI don’t survive. In the webinar, 18 Months of Sticking to it: Dedicated team site care using gum mastic…
Expert Recommendations on Improving Surgical Care 3 Questions With… features some of the finest thought leaders in healthcare specialties such as Infection Prevention, Vascular Access, Surgical Care and more. These experts answer questions on the latest insights, evidence and current practices. For our newest 3 Questions With… Eloquest Healthcare is proud to feature Maureen Spencer, RN, M.Ed.,…
Eloquest Healthcare is excited to feature Gwen Borlaug, MPH, CIC, FAPIC! Gwen worked at the Wisconsin Division of Public Health (DPH) as the Director of the Healthcare-Associated Infection Prevention Program and as an infection prevention epidemiologist. She launched a statewide public health initiative to reduce surgical site infections, using a surgical care champion to provide peer-to-peer…
Swapna Kakani was diagnosed at birth with a rare chronic disease, Short Bowel Syndrome. For 27 years, Swapna has lived with supplemental intravenous nutrition and a feeding tube (from 0-24 she had a gastrostomy tube and from 24 onwards she has had an ileostomy). She has undergone several surgeries at multiple hospitals throughout the United…
Our newest edition of 3 Questions With… 3 Questions With… features some of the finest thought leaders in healthcare specialties such as Infection Prevention, Vascular Access, Surgical Care and more. These experts answer questions on the latest insights, evidence and current practices. For our newest 3 Questions With… Eloquest Healthcare is proud to feature Gwen…
“Up to 90% of hospitalized patients can require a PVAD during their stay, however, greater than 60% of PVADs fail due to dislodgement, phlebitis, occlusion, infiltration, or infection.”¹ PVAD infections are so prevalent that the topic “Infections from Peripherally Inserted IV Lines” became number 9 in the ECRI Institute’s 2019 Top 10 Patient Safety Concerns.…
The access to, use of, and quality of health care can vary based on socioeconomic status, which can be measured by income, education, and/or occupation.1,2 Socioeconomic factors can be associated with various health outcomes, one of them being surgical site infection (SSI) which affects up to 5% of surgical procedures nationwide.3 However, the association between…
The hectic nature of the holiday season, which brings joy for most, also brings burnout. At the same time, we’re also busy establishing resolutions for the new year (or new decade!), the goals set are likely to fail or be a non-starter once the exhaustion catches up. This is especially true for those working in…
As 2019 ends, we would like to thank you for being part of the Eloquest Healthcare Blog! We hope you have found our posts both informative and impactful to your professional career. We kicked 2019 off with new clinical evidence reviewing the qualitative and quantitative evidence supporting the use of Detachol® Liquid Adhesive for the…
Surgical site infection (SSI) is a significant postoperative complication that increases morbidity, mortality, and length of stay for surgical patients[1]. On average, 300,000 to 500,000 people develop SSI annually in the United States[1], with 3% of SSIs being fatal and an overall national cost of $10 billion per year[2]. Reducing the risk of SSI begins…